Vertex Pharmaceuticals, Inc. (VRTX)

463.42 +4.21 (+0.92%) USD  |  NASDAQ  |  Dec 24, 10:54
More

Vertex Pharmaceuticals CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for VRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Amgen, Inc. Upgrade
Eli Lilly & Co. Upgrade
IDEXX Laboratories, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade